US based Baylor College of Medicine (BCM) has joined hands with Indian pharmaceutical company Biological E Limited (BE) for the development of a safe and effective Covid-19 vaccine.
Hyderabad-headquartered BE has licensed the recombinant protein COVID-19 vaccine candidate developed at Baylor.
India has recorded 33,87,500 coronavirus cases and 61,529 fatalities due to the disease, while the US is leading the chart with over 5,869,000 cases and 180,800 deaths.
